Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America

Biological therapies have revolutionized the treatment of several cancers and systemic immune-mediated inflammatory conditions. Expiry of patents protecting a number of biologics has provided the opportunity to commercialize highly similar versions, known as biosimilars. Biosimilars are approved by...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheinberg, Morton, Pineda, Carlos, Castañeda-Hernández, Gilberto, Zarbá, Juan José, Damião, Aderson, Arantes Jr, Luiz H, Jacobs, Ira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152448/
https://www.ncbi.nlm.nih.gov/pubmed/30156950
http://dx.doi.org/10.1080/19420862.2018.1484977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152448/
https://www.ncbi.nlm.nih.gov/pubmed/30156950
http://dx.doi.org/10.1080/19420862.2018.1484977

Ejemplares similares